Literature DB >> 25611551

The CD4 C868T Polymorphism and Its Correlation with HIV-1 Infection in a Chinese Population.

Yu Lu1, Junrong Wu, Xue Qin, Li Xie, Liping Ma, Xiuli Huang, Jiangyang Zhao, Yanqiong Liu, Xuejie Chen, Shan Li.   

Abstract

Previous studies performed in Kenya have suggested that the C868T single nucleotide polymorphism (SNP) in CD4 increases the risk of HIV-1 acquisition; however, no relevant study has been conducted in China. To evaluate the influence of this SNP on risk of HIV-1 infection in a Chinese population, the CD4 genotype was determined by DNA sequencing in 101 HIV-1 patients and 102 healthy controls. No significant differences in the genotype and allele distributions of this polymorphism were observed among the patient and control groups. Additionally, binary logistic regression analyses adjusted by age and gender revealed that the C868T polymorphism was not associated with risk of HIV-1 infection. Furthermore, when analyses of genotype and allele frequencies were stratified by gender, similar nonsignificant results were found. Our study demonstrates a null association between the CD4 C868T polymorphism and an individual's susceptibility of HIV-1 acquisition in a Chinese population. Further studies are warranted to confirm these results.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25611551      PMCID: PMC4426317          DOI: 10.1089/AID.2014.0303

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  28 in total

1.  A single amino acid substitution in a common African allele of the CD4 molecule ablates binding of the monoclonal antibody, OKT4.

Authors:  S Lederman; J A DeMartino; B L Daugherty; I Foeldvari; M J Yellin; A M Cleary; N Berkowitz; I Lowy; N S Braunstein; G E Mark
Journal:  Mol Immunol       Date:  1991-11       Impact factor: 4.407

2.  Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Authors:  M Samson; F Libert; B J Doranz; J Rucker; C Liesnard; C M Farber; S Saragosti; C Lapoumeroulie; J Cognaux; C Forceille; G Muyldermans; C Verhofstede; G Burtonboy; M Georges; T Imai; S Rana; Y Yi; R J Smyth; R G Collman; R W Doms; G Vassart; M Parmentier
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

3.  Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya.

Authors:  K R Fowke; N J Nagelkerke; J Kimani; J N Simonsen; A O Anzala; J J Bwayo; K S MacDonald; E N Ngugi; F A Plummer
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

4.  Infant CD4 C868T polymorphism is associated with increased human immunodeficiency virus (HIV-1) acquisition.

Authors:  R Y Choi; C Farquhar; J Juno; D Mbori-Ngacha; B Lohman-Payne; F Vouriot; S Wayne; J Tuff; R Bosire; G John-Stewart; K Fowke
Journal:  Clin Exp Immunol       Date:  2010-02-02       Impact factor: 4.330

5.  Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1.

Authors:  Huanliang Liu; Yon Hwangbo; Sarah Holte; Jean Lee; Chunhui Wang; Nicole Kaupp; Haiying Zhu; Connie Celum; Lawrence Corey; M Juliana McElrath; Tuofu Zhu
Journal:  J Infect Dis       Date:  2004-08-02       Impact factor: 5.226

Review 6.  Elite HIV controllers: myth or reality?

Authors:  Nitin K Saksena; Berta Rodes; Bin Wang; Vincent Soriano
Journal:  AIDS Rev       Date:  2007 Oct-Dec       Impact factor: 2.500

7.  Associations of chemokine receptor polymorphisms With HIV-1 mother-to-child transmission in sub-Saharan Africa: possible modulation of genetic effects by antiretrovirals.

Authors:  Kumud K Singh; Michael D Hughes; Jie Chen; Kelesitse Phiri; Christine Rousseau; Louise Kuhn; Anna Coutsoudis; J Brooks Jackson; Laura A Guay; Philippa Musoke; Francis Mmiro; Richard D Semba; Stephen A Spector
Journal:  J Acquir Immune Defic Syndr       Date:  2008-11-01       Impact factor: 3.731

8.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

9.  A common CD4 gene variant is associated with an increased risk of HIV-1 infection in Kenyan female commercial sex workers.

Authors:  Julius O Oyugi; Françoise C M Vouriot; Judie Alimonti; Stephen Wayne; Ma Luo; Allison M Land; Zhujun Ao; Xiaojian Yao; Rafick P Sekaly; Lawrence J Elliott; J Neil Simonsen; T Blake Ball; Walter Jaoko; Joshua Kimani; Francis A Plummer; Keith R Fowke
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

10.  Stromal cell-derived factor 1 polymorphism in patients infected with HIV and implications for AIDS progression in Tunisia.

Authors:  Sameh Amara; Jorge Domenech; Faouzi Jenhani
Journal:  HIV AIDS (Auckl)       Date:  2010-10-06
View more
  2 in total

1.  Preparation and characterization of monoclonal antibodies recognizing two CD4 isotypes of Microminipigs.

Authors:  Shino Ohshima; Tatsuya Matsubara; Asuka Miyamoto; Atsuko Shigenari; Noriaki Imaeda; Masaki Takasu; Masafumi Tanaka; Takashi Shiina; Shingo Suzuki; Noriaki Hirayama; Hitoshi Kitagawa; Jerzy K Kulski; Asako Ando; Yoshie Kametani
Journal:  PLoS One       Date:  2020-11-25       Impact factor: 3.240

2.  Three functional mutation sites affect the immune response of pigs through altering the expression pattern and IgV domain of the CD4 protein.

Authors:  Weiya Zhang; Juan Ni; Jie Zhang; Lu Zhang; Huanhuan Zhou; Changzhi Zhao; Mengjin Zhu; Haiyan Wang; Jianlin Han; Xinyun Li; Shuhong Zhao
Journal:  BMC Mol Cell Biol       Date:  2020-12-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.